Long-term survival in a patient with chronic myelogenous leukemia without any treatment

AUTHORS

A Shahriari 1 , * , HR Emaami 1

AUTHORS INFORMATION

1 Iran

How to Cite: Shahriari A, Emaami H. Long-term survival in a patient with chronic myelogenous leukemia without any treatment, J Kermanshah Univ Med Sci. 2002 ; 6(2):e81011.

ARTICLE INFORMATION

Journal of Kermanshah University of Medical Sciences: 6 (2); e81011
Published Online: September 19, 2002
Article Type: Case Report
Received: April 11, 2002
Accepted: September 11, 2002

Crossmark

CHEKING

READ FULL TEXT
Abstract

Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy,   average survival of these  patients is   3-5 years. All of the   long term survivors  of CML   have been  treated patients. Here we are reporting on a  long term survivor (more than 10 years)  without treatment.

Keywords

Chronic myelogenous leukemia survival clinical course

© 2002, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

The full text of this article is available on PDF

COMMENTS

LEAVE A COMMENT HERE: